Drugs controlled by the German Narcotic Drugs Act
(Redirected from Anlage II)
The following drugs are controlled by the German Narcotic Drugs Act (German: Betäubungsmittelgesetz or BtMG). Trade and possession of these substances without licence or prescription is considered illegal; prescription is illegal for drugs on Anlage I and II and drugs on Anlage III require a special prescription form.
Anlage I
[edit]Anlage I controlled substances are non-tradable without a permit from the German government, granted only for scientific or other public interest purposes.[1][2]
| INN | Trivial name | German IUPAC |
|---|---|---|
| Acetorphine | {4,5a-Epoxy-7a-[(R)-2-hydroxypentan-2-yl]-6-methoxy-17-methyl-6,14-ethenomorphinan-3-yl}acetat | |
| Acetyldihydrocodeine | (4,5a-Epoxy-3-methoxy-17-methylmorphinan-6a-yl)acetat | |
| Acetylmethadol | (6-Dimethylamino-4,4-diphenyl-heptan-3-yl)acetat | |
| α-Methylacetylfentanyl | N-Phenyl-N-[1-(1-phenyl-propan-2-yl)-4-piperidyl]acetamid | |
| Allylescaline | 4-Allyloxy-3,5-dimethoxy-phenethylazan | |
| Allylprodine | (3-Allyl-1-methyl-4-phenyl-4-piperidyl)propionat | |
| Alphacetylmethadol | [(3R,6R)-6-Dimethylamino-4,4-diphenylheptan-3-yl]acetat | |
| Alphameprodine | [(3RS,4SR)-3-Ethyl-1-methyl-4-phenyl-4-piperidyl]propionat | |
| Alphamethadol | (3R,6R)-6-Dimethylamino-4,4-diphenylheptan-3-ol | |
| Alphaprodine | [(3RS,4SR)-1,3-Dimethyl-4-phenyl-4-piperidyl]propionat | |
| 5-IT (5-API) | 1-(1H-Indol-5-yl)propan-2-amin | |
| Anileridine | Ethyl[1-(4-aminophenethyl)-4-phenyl-piperidin-4-carboxylat) | |
| BDB | 1-(1,3-Benzodioxol-5-yl)butan-2-ylazan | |
| Benzethidine | Ethyl{1-[2-benzyloxy)ethyl]-4-phenyl-piperidin-4-carboxylat} | |
| Benzphetamine | (Benzyl)(methyl)(1-phenylpropan-2-yl)azan | |
| 3',4'-Methylenedioxy-α-pyrrolidinopropiophenone (MDPPP) | 1-(1,3-Benzodioxol-5-yl)-2-(pyrrolidin-1-yl)propan-1-on | |
| Benzylfentanyl | N-(1-Benzyl-4-piperidyl)-N-phenyl-propanamid | |
| Benzylmorphine | 3-Benzyloxy-4,5a-epoxy-17-methylmorphin-7-en-6a-ol | |
| Betacetylmethadol | [(3S,6R)-6-Dimethylamino-4,4-diphenylheptan-3-yl]acetat | |
| Betameprodine | [(3RS,4RS)-3-Ethyl-1-methyl-4-phenyl-4-piperidyl]propionat | |
| Betamethadol | (3S,6R)-6-Dimethylamino-4,4-diphenylheptan-3-ol | |
| Betaprodine | [(3RS,4RS)-1,3-Dimethyl-4-phenyl-4-piperidyl]propionat | |
| Bezitramide | 4-[4-(2-Oxo-3-propionyl-2,3-dihydrobenzimidazol-1-yl)piperidino]-2,2,-diphenyl-butannitril | |
| 25B-NBOMe (2C-B-NBOMe) | 2-(4-Brom-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamin | |
| 25N-NBOMe (2C-N-NBOMe) | 2-(2,5-Dimethoxy-4-nitrophenyl)-N-[(2-methoxyphenyl)methyl]ethanamin | |
| Brolamphetamine | Dimethoxybromamphetamine (DOB) | (RS)-1-(4-Brom-2,5-dimethoxy-phenyl)propan-2-ylazan |
| 2C-B (BDMPEA) | 4-Brom-2,5-dimethoxyphenethyl-azan | |
| Cannabis (Marijuana, plants of the species Cannabis) (Except for Cannabis permitted under Anlage III) | ||
| Hashish | ||
| Carfentanil | Methyl[1-phenethyl-4-(N-phenyl-propanamido)piperidin-4-carboxylat] | |
| Cathinone | (S)-2-Amino-1-phenylpropan-1-on | |
| 2C-C | 2-(4-Chlor-2,5-dimethoxyphenyl)ethanamin | |
| 2C-D (2C-M) | 2-(2,5-Dimethoxy-4-methylphenyl)ethanamin | |
| 2C-E | 2-(4-Ethyl-2,5-dimethoxyphenyl)ethanamin | |
| 2C-I | 4-lod-2,5-dimethoxyphenethyl-azan | |
| 6-Cl-MDMA | [1-(6-Chlor-1,3-benzodioxol-5-yl)propan-2-yl](methyl)azan | |
| Clephedrone ( 4-CMC, 4-Chloromethcathinone) | 1-(4-Chlorphenyl)-2-(methylamino)propan-1-on | |
| Clonitazene | {2-[2-(4-Chlorbenzyl)-5-nitrobenzimidazol-1-yl]ethyl}diethylazan | |
| 25C-NBOMe (2C-C-NBOMe) | 2-(4-Chlor-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamin | |
| Codeine-N-oxide | 4,5a-Epoxy-3-methoxy-17-methylmorphin-7-en-6a-ol-17-oxid | |
| Codoxime | (4,5a-Epoxy-3-methoxy-17-methylmorphinan-6-yliden-aminooxy)essigsäure | |
| 2C-P | 2-(2,5-Dimethoxy-4-propylphenyl)ethanamin | |
| 2C-T-2 | 4-Ethylsulfanyl-2,5-dimethoxy-phenetylazan | |
| 2C-T-7 | 2,5-Dimethoxy-4-(propylsulfanyl)phenethylazan | |
| Desomorphine | Dihydrodesoxymorphine | 4,5a-Epoxy-17-methyl-morphinan-3-ol |
| Diampromide | N-{2-[(Methyl)(phenetyl)amino]propyl}-N-phenylpropanamid | |
| Diethoxybromoamphetamine | 1-(4-Brom-2,5-diethoxyphenyl)propan-2-ylazan | |
| Diethylthiambutene | Diethyl(1-methyl-3,3-di-2-thienylallyl)azan | |
| N,N-Diethyltryptamine (Diethyltryptamine, DET) | Diethyl[2-(indol-3-yl)ethyl]azan | |
| Dihydroetorphine (18,19-Dihydroetorphine) | (5R,6R,7R,14R)-4,5a-Epoxy-7a-[(R)-2-hydroxypentan-2-yl]-6-methoxy-17-methyl-6,14-ethanomorphinan-3-ol | |
| Dimenoxadol | (2-Dimethylaminoethyl)[(ethoxy)(diphenyl)acetat] | |
| Dimepheptanol | Methadole | 6-Dimethylamino-4,4-diphenyl-heptan-3-ol |
| Dimethoxyamphetamine (DMA) | 1-(2,5-Dimethoxyphenyl)propan-2-ylazan | |
| Dimethoxyethylamphetamine (DOET) | 1-(4-Ethyl-2,5-dimethoxyphenyl)propan-2-ylazan | |
| Dimethoxymethamphetamine (DMMA) | 1-(3,4-Dimethoxyphenyl)-N-methylpropan-2-amin | |
| Dimethoxymethylamphetamine (DOM, STP) | (RS)-1-(2,5-Dimethoxy-4-methylphenyl)propan-2-ylazan | |
| Dimethylheptyltetrahydrocannabinol (DMHP) | 6,6,9-Trimethyl-3-(3-methyl-octan-2-yl)-7,8,9,10-tetra-hydro-6H-benzo(c) chromen-1-ol | |
| Dimethylthiambutene | Dimethyl(1-methyl-3,3-di-2-thienylallyl)azan | |
| N,N-Dimethyltryptamine (Dimethyltryptamine, DMT) | [2-(Indol-3-yl) ethyl]dimethyl-azan | |
| Dioxaphetylbutyrate | Ethyl-(4-morpholino-2,2-diphenylbutanoat) | |
| Dipipanone | 4,4-Diphenyl-6-piperidinoheptan-3-on | |
| DOC | 1-(4-Chlor-2,5-dimethoxyphenyl)propan-2-ylazan | |
| Drotebanol | 3,4-Dimethoxy-17-methyl-morphinan-6β,14-diol | |
| N-Ethylbuphedrone (NEB) | 2-(Ethylamino)-1-phenylbutan-1-on | |
| 4-Ethylmethcathinone (4-EMC) | 1-(4-Ethylphenyl)-2-(methylamino)propan-1-on | |
| Ethylmethylthiambutene | (Ethyl)(methyl)(1-methyl-3,3-di-2-thienylallyl)azan | |
| Ethylone (βk-MDEA, MDEC) | 1-(1,3-Benzodioxol-5-yl)-2-(ethylamino)propan-1-on | |
| Ethylpiperidylbenzilate | (1-Ethyl-3-piperidyl)benzilat | |
| Eticyclidine | PCE | (Ethyl(1-phenylcyclohexyl)azan |
| Etonitazene | {2-[2-(4-Ethoxybenzyl)-5-nitrobenzimidazol-1-yl]ethyl}diethylazan | |
| Etoxeridine | Ethyl{1-[2-(2-hydroxyethoxy)ethyl]-4-phenylpiperidin-4-carboxylat} | |
| Etryptamine | α-Ethyltryptamine | 1-(Indol-3-yl)butan-2-ylazan |
| FLEA | N-[1-(1,3-Benzodioxol-5-yl)propan-2-yl]-N-methyl-hydroxylamin | |
| 4-Fluoroamphetamine (4-FA, 4-FMP) | (RS)-1-(4-Fluorphenyl)propan-2-amin | |
| 4-Fluorofentanyl | N-(4-Fluorphenyl)-N-(1-phenethyl-4-piperidyl)propanamid | |
| 2-Fluoromethamphetamine (2-FMA) | 1-(2-Fluorphenyl)-N-methylpropan-2-amin | |
| 3-Fluoromethamphetamine (3-FMA) | 1-(3-Fluorphenyl)-N-methylpropan-2-amin | |
| Furethidine | Ethyl{4-phenyl-1-[2-tetra-hydrofurfuryloxy)ethyl]piperidin-4-carboxylat} | |
| Heroin (Diacetylmorphin, Diamorphine); except for use permitted under Anlage II and Anlage III (under the name Diamorphine) | [(5R,6S)-4,5-Epoxy-17-methyl-morphin-7-en-3,6-diyl]diacetat | |
| Hydromorphinol | 14-Hydroxydihydromorphin | 4,5a-Epoxy-17-methyl-morphinan-3,6a,14-triol |
| N-Hydroxyamphetamine (NOHA) | N-(1-Phenylpropan-2-yl)hydroxylamin | |
| β-Hydroxyfentanyl | N-[1-(2-Hydroxy-2-phenyl-ethyl)-4-piperidyl]-N-phenylpropanamid | |
| Methylenedioxyhydroxyamphetamine (N-Hydroxy-MDA, MDOH) | N-[1-(1,3-Benzodioxol-5-yl) propan-2-yl]hydroxylamin | |
| β-Hydroxy-3-methyl-fentanyl (Ohmefentanyl) | N-[1-(2-Hydroxy-2-phenyl-ethyl)-3-methyl-4-piperidyl]-N-phenylpropanamid | |
| Hydroxypethidine | Ethyl[4-(3-hydroxyphenyl)-1-methylpiperidin-4-carboxylat] | |
| 25I-NBOMe (2C-I-NBOMe) | 2-(4-lod-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamin | |
| Lefetamine | SPA | [(R)-1,2-Diphenylethyl]dimethylazan |
| Levomethorphan | (9R,13R,14R)-3-Methoxy-17-methylmorphinan | |
| Levophenacylmorphan | 2-[(9R,13R,14R)-3-Hydroxy-morphinan-17-yl]-1-phenyl-ethanon | |
| Lofentanil | Methyl[(3R,4S)-3-methyl-1-phenethyl-4-(N-phenyl-propanamido)piperidin-4-carboxylat] | |
| Lysergide | N,N-Diethyl-D-lysergamide (LSD, LSD-25) | N,N-Diethyl-6-methyl-9,10-didehydroergolin-8β-carboxamid |
| Methallylescaline (MAL) | 3,5-Dimethoxy-4-(2-methyl-allyloxy)phenethylazan | |
| MBDB | [1-(1,3-Benzodioxol-5-yl)butan-2-yl](methyl)azan | |
| Mebroqualone | 3-(2-Bromphenyl)2-methyl-chinazolin-4(3H)-on | |
| Mecloqualone | 3-(2-Chlorphenyl)-2-methyl-chinazolin-4(3H)-on | |
| Mescaline | 3,4,5-Trimethoxyphenethylazan | |
| Metazocine | 3,6,11-Trimethyl-1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-8-ol | |
| Methcathinone (Ephedrone) | 2-Methylamino-1-phenylpropan-1-on | |
| Methiopropamine (MPA) | N-Methyl-1-(thiophen-2-yl)propan-2-amin | |
| Methoxetamine (MXE) | 2-(Ethylamino)-2-(3-methoxyphenyl)cyclohexanon | |
| Methoxyamphetamine (PMA) | 1-(4-Methoxyphenyl)propan-2-ylazan | |
| 5-Methoxy-diisopropyltryptamine (5-MeO-DIPT) | Diisopropyl[2-(5-methoxyindol-3-yl)ethyl]azan | |
| 5-Methoxy-DMT (5-MeO-DMT) | [2-(5-Methoxyindol-3-yl)ethyl]dimethylazan | |
| Methoxymethamphetamine (PMMA) | [1-(4-Methoxyphenyl)propan-2-yl](methyl)azan | |
| Methoxymethylenedioxyamphetamine (MMDA) | 1-(7-Methoxy-1,3-benzodioxol-5-yl)propan-2–ylazan | |
| PCMPA | (3-Methoxypropyl)(1-phenyl-cyclohexyl)azan | |
| Methylaminorex (4-Methylaminorex) | 4-Methyl-5-phenyl-4,5-dihydro-1,3-oxazol-2-ylazan | |
| 4-Methylbuphedrone (4-MeMABP) | 2-(Methylamino)-1-(4-methylphenyl)butan-1-on | |
| Methyldesorphine | 4,5a-Epoxy-6,17-dimethyl-morphin-6-en-3-ol | |
| Methyldihydromorphine | 4,5a-Epoxy-6,17-dimethyl-morphinan-3,6a-diol | |
| Methylenedioxyethylamphetamine (N-Ethyl-MDA, MDE, MDEA) | [1-(1,3-Benzodioxol-5-yl)propan-2-yl](ethyl)azan | |
| Methylenedioxymethamphetamine (MDMA) | [1-(1,3-Benzodioxol-5-yl)propan-2-yl](methyl)azan | |
| α-Methylfentanyl | N-Phenyl-N-[1-(1-phenylpropan-2-yl)-4-piperidyl]propanamid | |
| 3-Methylfentanyl (Mefentanyl) | N-(3-Methyl-1-phenethyl-4-piperidyl)-N-phenylpropanamid | |
| Methylmethaqualone | 3-(2,4-Dimethylphenyl)-2-methyl-chinazolin-4(3H)on | |
| 3-Methylmethcathinone (3-MMC) | 2-(Methylamino)-1-(3-methylphenyl)propan-1-on | |
| 4-Methylmethcathinone (Mephedrone) | 1-(4-Methylphenyl)-2-methylaminopropan-1-on | |
| Desmethylprodine (MPPP) | (1-Methyl-4-phenyl-4-piperidyl)propionat | |
| Methyl-3-phenylpropylamine (1M-3PP) | (Methyl)(3-phenylpropyl)azan | |
| Methylphenyltetrahydropyridine (MPTP) | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridin | |
| Methylpiperidylbenzilate | (1-Methyl-3-piperidyl)benzilat | |
| 4-Methylthioamphetamine (4-MTA) | 1-[4-(Methylsulfanyl)phenyl]propan-2-ylazan | |
| α-Methylthiofentanyl | N-Phenyl-N-{1-[1-(2-thienyl)propan-2-yl]-4-piperidyl}propanamid | |
| 3-Methylthiofentanyl | N-{3-Methyl-1-[2-(2-thienyl)ethyl]-4-piperidyl}-N-phenyl-propanamid | |
| α-Methyltryptamine (α-MT, AMT) | N-{3-Methyl-1-[2-(2-thienyl)ethyl]-4-piperidyl}-N-phenyl-propanamid | |
| Metopon | 5-Methyldihydromorphinone | 4,5a-Epoxy-3-hydroxy-5,17-dimethylmorphinan-6-on |
| Morpheridine | Ethyl(1-(2-morpholinoethyl)-4-phenylpiperidin-4-carboxylat) | |
| Morphine-N-oxide | (5R,6S)-4,5-Epoxy-3,6-dihydroxy-17-methylmorphin-7-en-17-oxid | |
| Myrophine | Myristylbenzylmorphine | (3-Benzyloxy-4,5a-epoxy-17-methylmorphin-7-en-6-yl)tetradecanoat |
| Nicomorphine | 3, 6-Dinicotinoylmorphine | 4,5a-Epoxy-17-methyl-morphin-7-en-3,6a-diyl)dinicotinat |
| Noracymethadol | (6-Methylamino-4,4-diphenyl-heptan-3-yl)acetat | |
| Norcodeine | N-Desmethylcodeine | 4,5a-Epoxy-3-methoxy-morphin-7-en-6a-ol |
| Norlevorphanol | (-)3-Hydroxymorphinane | (9R,13R,14R)-Morphinan-3-ol |
| Normorphine | Desmethylmorphine | 4,5a-Epoxymorphin-7-en-3,6a-diol |
| Norpipanone | 4,4-Diphenyl-6-piperidinohexan-3-on | |
| Parahexyl | 3-Hexyl-6, 6, 9-trimethyl-7, 8, 9, 10-tetrahydro-6H-benzo[c]chromen-1-ol | |
| PCPr | (1-Phenylcyclohexyl)(propyl)azan | |
| Pentylone (βk-MBDP) | 1-(1,3-Benzodioxol-5-yl)-2-(methylamino)pentan-1-on | |
| Phenadoxone | 6-Morpholino-4,4-diphenyl-heptan-3-on | |
| Phenampromide | N-Phenyl-N-(1-piperidinopropan-2-yl)propanamid | |
| Phenazocine | 6,11-Dimethyl-3-phenethyl-1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-8-ol | |
| Phencyclidine | PCP | 1-(1-Phenylcyclohexyl)piperidin |
| Phenethylphenylacetoxypipederidine (PEPAP) | (1-Phenethyl-4-phenyl-4-piperidyl)acetat | |
| Phenethylphenyltetrahydropyridine (PEPTP) | 1-Phenethyl-4-phenyl-1,2,3,6-tetrahydropyridin | |
| Phenpromethamine | 1-Methylamino-2-phenyl-propan (PPMA) | (Methyl)(2-phenylpropyl)azan |
| Phenomorphan | 17-Phenethylmorphinan-3-ol | |
| Phenoperidine | Ethyl [1-(3-hydroxy-3-phenyl-propyl)-4-phenylpiperidin-4-carboxylat] | |
| Piminodine | Ethyl[1-(3-anilinopropyl)-4-phenylpiperidin-4-carboxylat] | |
| α-Pyrrolidinopentiophenone (α-PPP) | 1-Phenyl-2-(pyrrolidin-1-yl)propan-1-one | |
| Proheptazine | (1,3-Dimethyl-4-phenylazepan-4-yl)propionat | |
| Properidine | Isopropyl(1-methyl-4-phenyl-piperidin-4-carboxylat) | |
| Psilocin (Psilotsin) | 3-(2-Dimethylaminoethyl)indol-4-ol | |
| 4-HO-DET | 3-(2-Diethylaminoethyl)indol-4-ol | |
| Psilocybin | [3-(2-Dimethylaminoethyl)indol-4-yl]dihydrogenphosphat | |
| Ethocybin | [3-(2-Diethylaminoethyl)indol-4-yl]dihydrogenphosphate | |
| 4'-Methyl-α-pyrrolidinopropiophenone (4-MePPP) | 2-(Pyrrolidin-1-yl)-1-(p-tolyl)propan-1-one | |
| Racemethorphan | (9RS,13RS,14RS)-3-Methoxy-17-methylmorphinan | |
| Rolicyclidine | PHP (PCPy) | 1-(1-Phenylcyclohexyl)pyrrolidin |
| Salvia divinorum | ||
| Tenamphetamine | Methylenedioxyamphetamine (MDA) | (RS)-1-(1,3-Benzodioxol-5-yl)propan-2-ylazan |
| Tenocyclidine | TCP | 1-[1-(2-Thienyl)cyclohexyl]piperidin |
| Tetrahydrocannabinols, the following isomers and their stereochemical variants: | ||
| Δ6a(10a)-Tetrahydrocannabinol (Δ6a(10a)-THC) | 6,6,9-Trimethyl-3-pentyl-7,8,9,10-tetrahydro-6H-benzo[c]chromen-1-ol | |
| Δ6a-Tetrahydrocannabinol (Δ6a-THC) | (9R,10aR)-6,6,9-Trimethyl-3-pentyl-8,9,10,10a-tetra-hydro-6H-benzo[c]chromen-1- ol(6aR,9R,10aR)-6,6,9-Trimethyl-3-pentyl-6a,9,10,10a-tetrahydro-6H-benzo[c] chromen-1-ol | |
| Δ7-Tetrahydrocannabinol (Δ7-THC) | ||
| Δ8-Tetrahydrocannabinol (Δ8-THC) | (6aR,10aR)-6,6,9-Trimethyl-3-pentyl-6a,7,10,10a-tetra-hydro-6H-benzo[c]chromen- 1-ol(6aR)-6,6,9-Trimethyl-3-pentyl-6a,7,8,9-tetrahydro-6H-benzo[c]chromen-1-ol | |
| Δ10-Tetrahydrocannabinol (Δ10-THC) | ||
| Δ9(11)-Tetrahydrocannabinol (Δ9(11)-THC) | (6aR,10aR)-6,6-Dimethyl-9-methylen-3-pentyl-6a,7,8,9,10,10a-hexahydro-6H-benzo[c] chromen-1-ol | |
| Thienyl fentanyl | N-Phenyl-N-(1-thenyl-4-piperidyl)propanamid | |
| Thienoamphetamine (Thiopropamine) | 1-(Thiophen-2-yl)propan-2-amin | |
| Thiofentanyl | N-Phenyl-N-{1-[2-(2-thienyl)ethyl]-4-piperidyl}propanamid | |
| Trimeperidine | (1,2,5-Trimethyl-4-phenyl-4-piperidyl)propionat | |
| 3,4,5-Trimethoxyamphetamine (TMA) | 1-(3,4,5-Trimethoxyphenyl)propan-2-ylazan | |
| 2,4,5-Trimethoxyamphetamine (TMA-2) | 1-(2,4,5-Trimethoxyphenyl)propan-2-ylazan |
As well as ester, ether, stereoisomers and salts of the substances listed in Anlage I.
Anlage II
[edit]Anlage II controlled substances are tradable, given special permission of the authorities, however not prescribable.[2][3] Narcotics on Anlage II are usually needed for the production of other narcotics on Anlage III.[citation needed]
| INN | Trivial name | German IUPAC |
|---|---|---|
| AB-CHMINACA | N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazol-3-carboxamid | |
| AB-FUBINACA | N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-[(4-fluorphenyl)methyl]-1H-indazol-3-carboxamid | |
| AB-PINACA | N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazol-3-carboxamid | |
| AB-001 | (Adamantan-1-yl)(1-pentyl-1H-indol-3-yl)methanone | |
| Acetylfentanyl (Desmethylfentanyl) | N-Phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]acetamid | |
| Acryloylfentanyl (Acrylfentanyl, ACF) | N-Phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]prop-3-enamid | |
| 5F-ADB (5F-MDMB-PINACA) | Methyl{2-[1-(5-fluorpentyl)-1H-indazol-3-carboxamid]-3,3-dimethylbutanoat} | |
| ADB-BINACA (ADB-BUTINACA, ADMB-BINACA) | N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-butyl-1H-indazol-3-carboxamid | |
| ADB-CHMINACA (MAB-CHMINACA) | N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazol-3-carboxamid | |
| ADB-FUBINACA | N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-[(4-fluorphenyl)methyl]-1H-indazol-3-carboxamid | |
| AH-7921 (Doxylam) | 3,4-Dichlor-N-{[1-(dimethylamino)cyclohexyl]methyl}benzamid | |
| AKB-48 (APINACA) | N-(Adamantan-1-yl)-1-pentyl-1H-indazol-3-carboxamid | |
| 5F-AKB-48 (5F-APINACA) | N-(Adamantan-1-yl)-1-(5-fluorpentyl)-1H-indazol-3-carboxamid | |
| AM-694 | [1-(5-Fluorpentyl)-1H-indol-3-yl](2-iodphenyl)methanon | |
| AM-1220 | {1-[(1-Methylpiperidin-2-yl)methyl]-1H-indol-3-yl}(naphthalin-1-yl)methanon | |
| AM-1220-Azepane | [1-(1-Methylazepan-3-yl)-1H-indol-3-yl](naphthalin-1-yl)methanon | |
| AM-2201 | [1-(5-Fluorpentyl)-1H-indol-3-yl] (naphthalin-1-yl)methanon | |
| AM-2232 | 5-[3-(Naphthalin-1-carbonyl)-1H-indol-1-yl]pentannitril | |
| AM-2233 | (2-Iodphenyl){1-[(1-methylpiperidin-2-yl)methyl]-1H-indol-3-yl}methanon | |
| AMB-CHMICA (MMB-CHMICA) | Methyl{2-[1-(cyclohexylmethyl)-1H-indol-3-carboxamido]-3-methylbutanoat} | |
| AMB-FUBINACA (FUB-AMB) | Methyl(2-{1-[(4-fluorphenyl)methyl]-1H-indazol-3-carboxamid}-3-methylbutanoat) | |
| Amphetaminil | (Phenyl)[(1-phenylpropan-2-yl)amino]acetonitril | |
| Amineptine | 7-(10,11-Dihydro-5H-dibenzo[a,d] [7]annulen-5-ylamino)heptansäure | |
| Aminorex | 5-Phenyl-4,5-dihydro-1,3-oxazol-2-ylazan | |
| 5-APB | 1-(Benzofuran-5-yl)propan-2-amin | |
| 6-APB | 1-(Benzofuran-6-yl)propan-2-amin | |
| APICA (SDB-001, 2NE1) | N-(Adamantan-1-yl)-1-pentyl-1H-indol-3-carboxamid | |
| alpha-Pyrrolidinohexiophenone (Alpha-PHP, α-PHP, PV-7) | 1-Phenyl-2-(pyrrolidin-1-yl)hexan-1-on | |
| α-Pyrrolidinoisohexanophenone (Alpha-PiHP, α-PiHP, 4-Methyl-α-PVP) | 4-Methyl-1-phenyl-2-(pyrrolidin-1-yl)pentan-1-on | |
| Alpha-PVT (α-PVT, alpha-Pyrrolidinopentiothiophenon) | 2-(Pyrrolidin-1-yl)-1-(thiophen-2-yl)pentan-1-on | |
| BB-22 (QUCHIC) | Chinolin-8-yl[1-(cyclohexylmethyl)-1H-indol-3-carboxylat] | |
| Benzylpiperazine (BZP) | 1-Benzylpiperazin | |
| Brorphine | 1-{1-[1-(4-Bromphenyl)ethyl]piperidin-4-yl}-1,3-dihydro-2H-benzimidazol-2-on | |
| Buphedrone | 2-(Methylamino)-1-phenylbutan-1-on | |
| Butalbital | 5-Allyl-5-isobutylbarbitursäure | |
| Butobarbital | 5-Butyl-5-ethylpyrimidin-2,4,6(1H,3H,5H)-trion | |
| Butylone | 1-(Benzo[d] [1,3]dioxol-5-yl)-2-(methylamino)butan-1-on | |
| Butyrfentanyl (Butyrylfentanyl) | N-Phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]butanamid | |
| Cetobemidone | Ketobemidone | 1-[4-(3-Hydroxyphenyl)-1-methyl-4-piperidyl]propan-1-on |
| 3-Chloromethcathinone (3-CMC, Clophedrone) | 1-(3-Chlorphenyl)-2-methylaminopropan-1-on | |
| meta-Chlorophenylpiperazine (m-CPP) | 1-(3-Chlorphenyl)piperazin | |
| D-Cocaine | Methyl(3β-(benzoyloxy)tropan-2alpha-carboxylat) | |
| CP 47,497 | 5-(1,1-Dimethylheptyl)-2-[(1RS,3SR)-3-hydroxycyclohexyl]-phenol | |
| CP 47,497-C6-Homolog | 5-(1,1-Dimethylhexyl)-2-[(1RS,3SR)-3-hydroxycyclohexyl]-phenol | |
| 5Cl-AKB-48 (5C-AKB-48, AKB-48Cl, 5Cl-APINACA, 5C-APINACA) | N-(Adamantan-1-yl)-1-(5-chlorpentyl)-1H-indazol-3-carboxamid | |
| 5Cl-JWH-018 (JWH-018 N-(5-Chlorpentyl)-Analogue) | [1-(5-Chlorpentyl)-1H-indol-3-yl](naphthalin-1-yl)methanon | |
| Clonazolam (Clonitrazolam) | 6-(2-Chlorphenyl)-1-methyl-8-nitro-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin | |
| CP 47,497-C8-Homolog | 5-(1,1-Dimethyloctyl)-2-[(1RS,3SR)-3-hydroxycyclohexyl]-phenol | |
| CP 47,497-C9 | 5-(1,1-Dimethylnonyl)-2-[(1RS,3SR)-3-hydroxycyclohexyl]-phenol | |
| Crotonylfentanyl | (2E)-N-Phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]but-2-enamid | |
| CUMYL-4CN-BINACA (SGT-78) | 1-(4-Cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazol-3-carboxamid | |
| CUMYL-5F-PEGACLONE (5F-Cumyl-PeGaClone, 5F-SGT-151) | 5-(5-Fluorpentyl)-2-(2-phenylpropan-2-yl)-2,5-dihydro-1H-pyrido[4,3-b]indol-1-on | |
| CUMYL-PEGACLONE (SGT-151) | 5-Pentyl-2-(2-phenylpropan-2-yl)-2,5-dihydro-1H-pyrido[4,3-b]indol-1-on | |
| CUMYL-5F-P7AICA (5-Fluoro-CUMYL-P7AICA, SGT-263) | 1-(5-Fluorpentyl)-N-(2-phenylpropan-2-yl)-1H-pyrrolo[2,3-b]pyridin-3-carboxamid | |
| Cyclobarbital | 5-(Cyclohex-1-en-1-yl)-5-ethylpyrimidin-2,4,6(1H,3H,5H)-trion | |
| Cyclopropylfentanyl | N-Phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]cyclopropancarboxamid | |
| Desoxypipradrol (2-DPMP) | 2-(Diphenylmethyl)piperidin | |
| Dextromethadone | (S)-6-Dimethylamino-4,4-diphenylheptan-3-on | |
| Dextromoramide | (S)-3-Methyl-4-morpholino-2,2-diphenyl-1-(pyrrolidin-1-yl)butan-1-on | |
| Dextropropoxyphene | [(2S,3R)-4-Dimethylamino-3-methyl-1,2-diphenylbutan-2-yl]propionat | |
| Diamorphine, only for the production of preparations for medical purposes | [(5R,6S)-4,5-Epoxy-17-methylmorphin-7-en-3,6-diyl]diacetat | |
| Diclazepam (2'-Chlorodiazepam) | 7-Chlor-5-(2-chlorphenyl)-1-methyl-1,3-dihydro-2H-1,4-benzodiazepin-2-on | |
| Difenoxin | (in doses higher than zu 0.5 mg base or with less than 5 % atropine sulphate) | 1-(3-Cyan-3,3-diphenylpropyl)-4-phenylpiperidin-4-carbonsäure |
| Dihydromorphine | 4,5a-Epoxy-17-methylmorphinan-3,6a-diol | |
| Dihydrothebaine | 4,5a-Epoxy-3,6-dimethoxy-17-methylmorphin-6-en | |
| Dimethocaine (DMC, Larocaine) | (3-Diethylamino-2,2-dimethylpropyl)-4-aminobenzoat | |
| Diphenidine (1,2-DEP, DPD, DND, 1,2-Diphenylethylpiperidine) | 1-(1,2-Diphenylethyl)piperidin | |
| 2,5-Dimethoxy-4-iodoamphetamine (DOI) | 1-(4-Iod-2,5-dimethoxyphenyl)propan-2-amin | |
| 3,4-Dimethylmethcathinone (3,4-DMMC) | 1-(3,4-Dimethylphenyl)-2-(methylamino)propan-1-on | |
| Diphenoxylate | (in doses higher than 2.5 mg base or with less than 1 % atropine sulphate) | Ethyl[1-(3-cyan-3,3-diphenylpropyl)-4-phenylpiperidin-4-carboxylat] |
| 4,4'-DMAR (para-Methyl-4-methylaminorex) | 4-Methyl-5-(4-methylphenyl)-4,5-dihydro-1,3-oxazol-2-amin | |
| EAM-2201 (5-fluoro-JWH-210) | (4-Ethylnaphthalin-1-yl)[1-(5-fluorpentyl)-1H-indol-3-yl]methanon | |
| Ecgonine | 3β-Hydroxytropan-2β-carbonsäure | |
| Erythroxylum coca | ||
| Etazene (Etodesnitazene) | N,N-Diethyl-2-{2-[(4-ethoxyphenyl)methyl]-1H-benzimidazol-1-yl}ethan-1-amin | |
| Ethcathinone | (RS)-2-(Ethylamino)-1-phenylpropan-1-on | |
| Ethchlorvynol | 1-Chlor-3-ethylpent-1-en-4-in-3-ol | |
| Ethinamate | (1-Ethinylcyclohexyl)carbamat | |
| 3-O-Ethylmorphine (Ethylmorphine) (in doses higher than 100 mg base) | 4,5a-Epoxy-3-ethoxy-17-methylmorphin-7-en-6a-ol | |
| Ethylphenidate | Ethyl[2-(phenyl)-2-(piperidin-2-yl) acetat] | |
| Etilamfetamine | N-Ethylamphetamine | (Ethyl)(1-phenylpropan-2-yl)azan |
| Etonitazepyne (N-Pyrrolidino Etonitazene) | 2-[(4-Ethoxyphenyl)methyl]-5-nitro-1-(2-pyrrolidin-1-ylethyl)-1H-benzimidazol | |
| Eutylone (N-Ethylnorbutylone, bk-EBDB) | 1-(1,3-Benzodioxol-5-yl)-2-(ethylamino)butan-1-on | |
| 4F-MDMB-BICA (4F-MDMB-BUTICA, 4FBC, 4FBCA, MDMB-073-F, 4F-MDMB-2201) | Methyl{2-[1-(4-fluorbutyl)-1H-indol-3-carboxamido]-3,3-dimethylbutanoat} | |
| 4F-MDMB-BINACA (4F-MDMB-BUTINACA, 4F-ADB) | Methyl{2-[1-(4-fluorbutyl)-1H-indazol-3-carboxamido]-3,3-dimethylbutanoat} | |
| 5F-ABICA (5F-AMBICA, 5-fluoro-ABICA, 5-fluoro-AMBICA) | N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluorpentyl)-1H-indol-3-carboxamid | |
| 5F-AB-PINACA (5-fluoro-AB-PINACA) | N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluorpentyl)-1H-indazol-3-carboxamid | |
| 5F-AMB (5-fluoro-AMB) | Methyl{2-[1-(5-fluorpentyl)-1H-indazol-3-carboxamido]-3-methylbutanoat} | |
| FDU-PB-22 | Naphthalin-1-yl{1[(4-fluorphenyl)methyl]-1H-indol-3-carboxylat} | |
| Fencamfamine | N-Ethyl-3-phenylbicyclo[2.2.1]heptan-2-amin | |
| Flephedrone (4-Fluoromethcathinone, 4-FMC) | 1-(4-Fluorphenyl)-2-(methylamino)propan-1-on | |
| Flualprazolam (2-Fluoro-Alprazolam, SCHEMBL7327360, Flu-Alp) | 8-Chlor-6-(2-fluorphenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-a] [1,4]benzodiazepin | |
| Flubromazepam | 7-Brom-5-(2-fluorphenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-on | |
| Flubromazolam | 8-Brom-6-(2-fluorphenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin | |
| 4-Fluoroisobutyrfentanyl (4-Fluorisobutyrylfentanyl, 4F-iBF, p-FIBF) | N-(4-Fluorphenyl)-2-methyl-N-[1-(2-phenylethyl)piperidin-4-yl]propanamid | |
| 4-Fluoromethamphetamine (4-FMA) | 1-(4-Fluorphenyl)-N-methylpropan-2-amin | |
| 3-Fluoromethcathinone (3-FMC) | 1-(3-Fluorphenyl)-2-(methylamino)propan-1-on | |
| Furanylfentanyl (FU-F) | N-Phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]furan-2-carboxamid | |
| 5F-JWH-122 (MAM-2201) | [1-(5-Fluorpentyl)-1H-indol-3-yl] (4-methylnaphthalin-1-yl)methanon | |
| p-Fluorophenylpiperazine (p-FPP) | 1-(4-Fluorphenyl)piperazin | |
| 4-Fluorotropacocaine | 3-(4-Fluorbenzoyloxy)tropan | |
| 5-Fluoro-UR-144 (XLR-11) | [1-(5-Fluorpentyl)-1H-indol-3-yl] (2,2,3,3-tetramethylcyclopropyl) methanon | |
| 5F-PB-22 (5F-QUPIC) | Chinolin-8-yl[1-(5-fluorpentyl)indol-3-carboxylat] | |
| 5F-SDB-006 | N-Benzyl-1-(5-fluorpentyl)-1H-indol-3-carboxamid | |
| FUB-PB-22 | Chinolin-8-yl{1-[(4-fluorphenyl)methyl]-1H-indol-3-carboxylat} | |
| Glutethimide | 3-Ethyl-3-phenylpiperidin-2,6-dion | |
| Isocodeine | 4,5a-Epoxy-3-methoxy-17-methylmorphin-7-en-6β-ol | |
| Isomethadone | 6-Dimethylamino-5-methyl-4,4-diphenylhexan-3-on | |
| Isotonitazene | N,N-Diethyl-2-{[4-(1-methylethoxy)phenyl]methyl}-5-nitro-1H-benzimidazol-1-ethanamin | |
| JWH-007 | (2-Methyl-1-pentyl-1H-indol-3-yl)(naphthalin-1-yl)methanon | |
| JWH-015 | (2-Methyl-1-propyl-1H-indol-3-yl)(naphthalin-1-yl)methanon | |
| JWH-018 | (Naphthalin-1-yl)(1-pentyl-1H-indol-3-yl)methanon | |
| JWH-019 | (Naphthalin-1-yl)(1-hexyl-1H-indol-3-yl)methanon | |
| JWH-073 | (Naphthalin-1-yl)(1-butyl-1H-indol-3-yl)methanon | |
| JWH-081 | (4-Methoxynaphthalin-1-yl)(1-pentyl-1H-indol-3-yl)methanon | |
| JWH-122 | (4-Methylnaphthalin-1-yl)(1-pentyl-1H-indol-3-yl)methanon | |
| JWH-200 | [1-(2-Morpholinoethyl)-1H-indol-3-yl](naphthalin-1-yl)methanon | |
| JWH-203 | 2-(2-Chlorphenyl)-1-(1-pentyl-1H-indol-3-yl)ethanon | |
| JWH-210 | (4-Ethylnaphthalin-1-yl)(1-pentyl-1H-indol-3-yl)methanon | |
| JWH-250 | 2-(2-Methoxyphenyl)-1-(1-pentyl-1H-indol-3-yl)ethanon | |
| JWH-251 | 2-(2-Methylphenyl)-1-(1-pentyl-1H-indol-3-yl)ethanon | |
| JWH-307 | [5-(2-Fluorphenyl)-1-pentyl-1H-pyrrol-3-yl](naphthalin-1-yl) methanon | |
| Levoamphetamine | Levamfetamine | (R)-1-Phenylpropan-2-ylazan |
| Levomethamphetamine (Levometamfetamine) | (R)-(Methyl)(1-phenylpropan-2-yl)azan | |
| Levomoramide | (R)-3-Methyl-4-morpholino-2,2-diphenyl-1-(pyrrolidin-1-yl)butan-1-on | |
| Levorphanol | (9R,13R,14R)-17-Methylmorphinan-3-ol | |
| Mazindol | 5-(4-Chlorphenyl)-2,5-dihydro-3H-imidazol[2,1-a]isoindol-5-ol | |
| 5F-MDMB-PICA (5F-MDMB-2201) | Methyl{2-[1-(5-fluorpentyl)-1H-indol-3-carboxamido]-3,3-dimethylbutanoat} | |
| MDMB-4en-PINACA | Methyl{2-[1-(pent-4-en-1-yl)-1H-indazol-3-carboxamido]-3,3-dimethylbutanoat} | |
| MDMB-CHMCZCA (EGMB-CHMINACA) | Methyl{2-[9-(cyclohexylmethyl)-9H-carbazol-3-carboxamido]-3,3-dimethylbutanoat} | |
| MDMB-CHMICA | Methyl{2-[1-(cyclohexylmethyl)-1H-indol-3-carboxamido]-3,3-dimethylbutanoat} | |
| Mefenorex | 3-Chlor-N-(1-phenylpropan-2-yl)propan-1-amin | |
| Meprobamate | (2-Methyl-2-propylpropan-1,3-diyl)dicarbamat | |
| 3-Methoxyphencyclidine (3-MeO-PCP) | 1-[1-(3-Methoxyphenyl)cyclohexyl]piperidin | |
| Mesocarb | (Phenylcarbamoyl)[3-(1-phenylpropan-2-yl)-1,2,3-oxadiazol-3-ium-5-yl]azanid | |
| Methamphetamine | (2S)-N-Methyl-1-phenylpropan-2-amin | |
| (RS)-Methamphetamine | (RS)-(Methyl)(1-phenylpropan-2-yl)azan | |
| Methadone intermediate (Premethadone) | 4-Dimethylamino-2,2-diphenylpentannitril | |
| Methaqualone | 2-Methyl-3-(2-methylphenyl)chinazolin-4(3H)-on | |
| Methedrone (4-Methoxymethcathinone, PMMC) | 1-(4-Methoxyphenyl)-2-(methylamino)propan-1-on | |
| Methoxyacetylfentanyl | 2-Methoxy-N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]acetamid | |
| p-Methoxyethylamphetamine (PMEA) | N-Ethyl-1-(4-methoxyphenyl)propan-2-amin | |
| 4-Methylamphetamine | 1-(4-Methylphenyl)propan-2-amin | |
| 2-Methyl-AP-237 | 1-[2-Methyl-4-(3-phenylprop-2-en-1-yl)piperazin-1-yl]butan-1-on | |
| Methylbenzylpiperazine (MBZP) | 1-Benzyl-4-methylpiperazin | |
| 3,4-Methylenedioxypyrovalerone (MDPV) | 1-(Benzo[d] [1,3]dioxol-5-yl)-2-(pyrrolidin-1-yl)pentan-1-on | |
| 4-Methylethcathinone (4-MEC) | 2-(Ethylamino)-1-(4-methylphenyl)propan-1-on | |
| Methylone (3,4-Methylenedioxy-N-methcathinone, MDMC) | 1-(Benzo[d] [1,3]dioxol-5-yl)-2-(methylamino)propan-1-on | |
| (RS;SR)-Methylphenidate | Methyl[(RS;SR)(phenyl)(2-piperidyl)acetat] | |
| Methyprylon | 3,3-Diethyl-5-methylpiperidin-2,4-dion | |
| Metonitazene | N,N-Diethyl-2-{2-[(4-methoxyphenyl)methyl]-5-nitro-1H-benzimidazol-1-yl}ethan-1-amin | |
| Poppy straw concentrate | ||
| MMB-2201 (5F-AMB-PICA, 5F-MMB-PICA) | Methyl{2-[1-(5-fluorpentyl)-1H-indol-3-carboxamido]-3-methylbutanoat} | |
| 5F-MN-18 (AM-2201 Indazolecarboxamide-Analog) | 1-(5-Fluorpentyl)-N-1-(naphthalin-1-yl)-1H-indazol-3-carboxamid | |
| Moramide intermediate (Premoramide) | 3-Methyl-4-morpholino-2,2-diphenylbutansäure | |
| MT-45 | 1-Cyclohexyl-4-(1,2-diphenylethyl)piperazin | |
| Naphyrone (Naphthylpyrovalerone) | 1-(Naphthalin-2-yl)-2-(pyrrolidin-1-yl)pentan-1-on | |
| NE-CHMIMO (JWH-018 N-(Cyclohexylmethyl)-Analogue) | [1-(Cyclohexylmethyl)-1H-indol-3-yl](naphthalin-1-yl)methanon | |
| N-Ethylhexedrone (Ethyl-Hexedrone, HexEn, Ethyl-Hex, NEH) | 2-(Ethylamino)-1-phenylhexan-1-on | |
| N-Ethylpentylone (Ephylone, βk-EBDP, βk-Ethyl-K) | 1-(1,3-Benzodioxol-5-yl)-2-(ethylamino)pentan-1-on | |
| Nicocodeine | 6-Nicotinoylcodein | (4,5a-Epoxy-3-methoxy-17-methylmorphin-7-en-6a-yl)nicotinat |
| Nicodicodine | 6-Nicotinoyldihydrocodein | (4,5a-Epoxy-3-methoxy-17-methylmorphinan-6a-yl)nicotinat |
| NM-2201 (CBL-2201) | Naphthalin-1-yl[1-(5-fluorpentyl)-1H-indol-3-carboxylat] | |
| Ocfentanil (A-3217) | N-(2-Fluorphenyl)-2-methoxy-N-[1-(2-phenylethyl)piperidin-4-yl]acetamid | |
| Oripavine | 4,5a-Epoxy-6-methoxy-17-methylmorphina-6,8-dien-3-ol | |
| Orthofluorofentanyl (2-Fluorofentanyl, 2F-F, 2-FF, o-FF) | N-(2-Fluorphenyl)-N-[1-(2-phenylethyl)piperidin-4-yl]propanamid | |
| Oxymorphone | 14-Hydroxydihydromorphinone | 4,5a-Epoxy-3,14-dihydroxy-17-methylmorphinan-6-on |
| Papaver bracteatum | ||
| Parafluorobutyrylfentanyl (Parafluorobutyrfentanyl, 4-Fluorobutyrfentanyl, 4F-BF, PFBF) | N-(4-Fluorphenyl)-N-[1-(2-phenylethyl)piperidin-4-yl]butanamid | |
| PB-22 (QUPIC) | Chinolin-8-yl(1-pentylindol-3-carboxylat) | |
| Pentedrone | 2-(Methylamino)-1-phenylpentan-1-on | |
| Pethidine intermediate A (Prepethidine) | 1-Methyl-4-phenylpiperidin-4-carbonitril | |
| Pethidine intermediate B (Norpethidine) | Ethyl(4-phenylpiperidin-4-carboxylat) | |
| Pethidine intermediate C (Pethidinic acid) | 1-Methyl-4-phenylpiperidin-4-carbonsäure | |
| Phendimetrazine | (2S,3S)-3,4-Dimethyl-2-phenylmorpholin | |
| Phenmetrazine | 3-Methyl-2-phenylmorpholin | |
| Pholcodine | Morpholinylethylmorphine (in doses higher than 20 mg base) | 4,5a-Epoxy-17-methyl-3-(2-morpholinoethoxy)morphin-7-en-6a-ol |
| Propiram | N-(1-Piperidinopropan-2-yl)-N-(2-pyridyl)propanamid | |
| Protonitazene | N,N-Diethyl-2-{2-[(4-propoxyphenyl)methyl]-5-nitro-1H-benzimidazol-1-yl}ethan-1-amin | |
| Pyrovalerone | 2-(Pyrrolidin-1-yl)-1-(p-tolyl)pentan-1-on | |
| α-Pyrrolidinopentiophenone (α-PVP) | 1-Phenyl-2-(pyrrolidin-1-yl)pentan-1-on | |
| Racemoramide | (RS)-3-Methyl-4-morpholino-2,2-diphenyl-1-(pyrrolidin-1-yl)butan-1-on | |
| Racemorphan | (9RS,13RS,14RS)-17-Methylmorphinan-3-ol | |
| RCS-4 | (4-Methoxyphenyl)(1-pentyl-1H-indol-3-yl)methanon | |
| RCS-4 ortho-Isomer (o-RCS-4) | (2-Methoxyphenyl)(1-pentyl-1H-indol-3-yl)methanon | |
| SDB-006 | N-Benzyl-1-pentyl-1H-indol-3-carboxamid | |
| Secbutabarbital | Butabarbital | 5-(Butan-2-yl)-5-ethylpyrimidin-2,4,6(1H,3H,5H)-trion |
| STS-135 (5F-2NE1) | N-(Adamantan-1-yl)-1-(5-fluorpentyl)-1H-indol-3-carboxamid | |
| Δ9-Tetrahydrocannabinol (Δ9-THC) | 6,6,9-Trimethyl-3-pentyl-6a,7,8,10a-tetrahydro-6H-benzo[c]chromen-1-ol | |
| Tetrahydrofuranylfentanyl (THF-F) | N-Phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]tetrahydrofuran-2-carboxamid | |
| Tetrahydrothebaine | 4,5a-Epoxy-3,6-dimethoxy-17-methylmorphinan | |
| Thebacon | Acetyldihydrocodeinone | (4,5a-Epoxy-3-methoxy-17-methylmorphin-6-en-6-yl)acetat |
| Thebaine | 4,5a-Epoxy-3,6-dimethoxy-17-methylmorphina-6,8-dien | |
| THJ-018 (JWH-018 Indazole-Analog) | (Naphthalin-1-yl)(1-pentyl-1H-indazol-3-yl)methanon | |
| THJ-2201 (AM-2201 Indazole-Analog) | [1-(5-Fluorpentyl)-1H-indazol-3-yl] (naphthalin-1-yl)methanon | |
| cis-Tilidine | Ethyl[(1RS,2RS)-2-dimethylamino-1-phenylcyclohex-3-encarboxylat] | |
| 3-Trifluoromethylphenylpiperazine (TFMPP) | 1-[3-(Trifluormethyl)phenyl]piperazin | |
| U-47700 | 3,4-Dichlor-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamid | |
| U-48800 | 2-(2,4-Dichlorphenyl)-N-[2-(dimethylamino)cyclohexyl]-N-methylacetamid | |
| UR-144 | (1-Pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanon | |
| Valerylfentanyl | N-Phenyl-N-[1-(2-phenylethyl) piperidin-4-yl]pentanamid | |
| Vinylbital | 5-Ethenyl-5-(pentan-2-yl)pyrimidin-2,4,6(1H,3H,5H)-trion | |
| Zipeprol | 1-Methoxy-3-[4-(2-methoxy-2-phenylethyl)piperazin-1-yl]-1-phenylpropan-2-ol |
As well as ester, ether and salts of the substances listed in Anlage II.
Anlage III
[edit]Anlage III controlled substances are tradable and prescribable, but only on a special prescription form. The prescription must be necessary in that its purpose cannot be met by other means.[4][5] Summary of Product Characteristics for these substances are restricted to professional circles.[6][clarification needed]
| INN | Trivial name | German IUPAC |
|---|---|---|
| Alfentanil | N-{1-[2-(4-Ethyl-5-oxo-4,5-dihydro-1H-tetrazol-1-yl)ethyl]-4-methoxymethyl-4-piperidyl}-N-phenylpropanamid | |
| Allobarbital | 5,5-Diallylbarbitursäure | |
| Alprazolam | (in doses higher than 1 mg) | 8-Chlor-1-methyl-6-phenyl-4H-[1,2,4]triazolo[4,3-a] [1,4]benzodiazepin |
| Amfepramone | (in doses higher than 22 mg base or sustained release doses higher than 64 mg base) | 2-Diethylamino-1-phenylpropan-1-on |
| Amfetamine | Amphetamine | (RS)-1-Phenylpropan-2-ylazan |
| Amobarbital | 5-Ethyl-5-isopentylbarbitursäure | |
| Barbital | 5,5-Diethylbarbitursäure | |
| Bromazepam | (in doses higher than 6 mg) | 7-Brom-5-(2-pyridyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-on |
| Brotizolam | (in doses higher than 0.25 mg) | 2-Brom-4-(2-chlorphenyl)-9-methyl-6H-thieno[3,2-f] [1,2,4]triazolo[4,3-a] [1,4]diazepin |
| Buprenorphine | (5R,6R,7R,14S)-17-Cyclopropyl-methyl-4,5-epoxy-7-[(S)-2-hydroxy-3,3-dimethylbutan-2-yl]-6-methoxy-6,14-ethanomorphinan-3-ol | |
| Camazepam | (7-Chlor-1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-1,4-enzodiazepin-3-yl)(dimethylcarbamat) | |
| Medicinal cannabis from state-controlled production | ||
| Cathine | (in doses higher than 40 mg base) | (1S,2S)-2-Amino-1-phenylpropan-1-ol |
| Chlordiazepoxide | (in doses higher than 25 mg) | 7-Chlor-2-methylamino-5-phenyl-3H-1,4-benzodiazepin-4-oxid |
| Clobazam | (in doses higher than 30 mg) | 7-Chlor-1-methyl-5-phenyl-1,3-dihydro-2H-1,5-benzodiazepin-2,4(5H)-dion |
| Clonazepam | (in doses higher than 2 mg) | 5-(2-Chlorphenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-on |
| Clorazepate | (in doses higher than 50 mg dipotassium salt) | (RS)-7-Chlor-2-oxo-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-3-carbonsäure |
| Clotiazepam | (in doses higher than 20 mg) | 5-(2-Chlorphenyl)-7-ethyl-1-methyl-1,3-dihydro-2H-thieno[2,3-e] [1,4]diazepin-2-on |
| Cloxazolam | 10-Chlor-11b-(2-chlorphenyl)-2,3,7,11b-tetrahydro[1,3]oxazolo[3,2-d] [1,4]benzodiazepin-6(5H)-on | |
| Cocaine (Benzoylecgoninmethylester) | Methyl[3β-(benzoyloxy)tropan-2β-carboxylat] | |
| Codeine (3-Methylmorphine) (in doses higher than 100 mg base or for treating addiction) | 4,5a-Epoxy-3-methoxy-17-methylmorphin-7-en-6a-ol | |
| Delorazepam | 7-Chlor-5-(2-chlorphenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-on | |
| Dexamfetamine | Dexamphetamin | (S)-1-Phenylpropan-2-ylazan |
| Dexmethylphenidate | Methyl[(R,R)(phenyl)(2-piperidyl)acetat] | |
| Diamorphine, only in preparations authorized for substitution therapy | [(5R,6S)-4,5-Epoxy-17-methylmorphin-7-en-3,6-diyl]diacetat | |
| Diazepam | (in doses higher than 10 mg) | 7-Chlor-1-methyl-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-on |
| Dihydrocodeine | (in doses higher than 100 mg base or for treating addiction) | 4,5a-Epoxy-3-methoxy-17-methylmorphinan-6a-ol |
| Dronabinol | (6aR,10aR)-6,6,9-Trimethyl-3-pentyl-6a,7,8,10a-tetrahydro-6H-benzo[c]chromen-1-ol | |
| Estazolam | (in doses higher than 2 mg) | 8-Chlor-6-phenyl-4H-[1,2,4]triazolo[4,3-a]benzodiazepin |
| Ethylloflazepate | Ethyl[7-chlor-5-(2-fluorphenyl)-2-oxo-2,3-dihydro-1H-1,4-benzodiazepin-3-carboxylat] | |
| Etizolam | 4-(2-Chlorphenyl)-2-ethyl-9-methyl-6H-thieno[3,2-f] [1,2,4]triazolo[4,3-a] [1,4]diazepin | |
| Etorphine | (5R,6R,7R,14R)-4,5-Epoxy-7-[(R)-2-hydroxypentan-2-yl]-6-methoxy-17-methyl-6,14-ethenomorphinan-3-ol | |
| Fenetylline | 1,3-Dimethyl-7-[2-(1-phenylpropan-2-ylamino)ethyl]-3,7-dihydro-2H-purin-2,6(1H)-dion | |
| Fenproporex | (in doses higher than 11 mg base) | (RS)-3-(1-Phenylpropan-2-ylamino)propannitril |
| Fentanyl | N-(1-Phenethyl-4-piperidyl)-N-phenylpropanamid | |
| Fludiazepam | 7-Chlor-5-(2-fluorphenyl)-1-methyl-1,3-dihydro-2H-1,4-benzodiazepin-2-on | |
| Flunitrazepam | 5-(2-Fluorphenyl)-1-methyl-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-on | |
| Flurazepam | (in doses higher than 30 mg) | 7-Chlor-1-(2-diethylaminoethyl)-5-(2-fluorphenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-on |
| Halazepam | (in doses higher than 120 mg) | 7-Chlor-5-phenyl-1-(2,2,2-trifluorethyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-on |
| Haloxazolam | 10-Brom-11b-(2-fluorphenyl)-2,3,7,11b-tetrahydro[1,3]oxazolo[3,2-d] [1,4]benzodiazepin-6(5H)-on | |
| Hydrocodone | Dihydrocodeinone | 4,5a-Epoxy-3-methoxy-17-methylmorphinan-6-on |
| Hydromorphone | Dihydromorphinone | 4,5a-Epoxy-3-hydroxy-17-methylmorphinan-6-on |
| γ-Hydroxybutyric acid (GHB) (in doses higher than 2 g acid) | 4-Hydroxybutansäure | |
| Ketazolam | (in doses higher than 45 mg) | 11-Chlor-2,8-dimethyl-12b-phenyl-8,12b-dihydro-4H-[1,3]oxazino[(3,2-d] [1,4]benzodiazepin-4,7(6H)-dion |
| Levacetylmethadol | Levomethadylacetat (LAAM) | [(3S,6S)-6-Dimethylamino-4,4- diphenylheptan-3-yl]acetat |
| Levomethadone | (R)-6-Dimethylamino-4,4-diphenylheptan-3-on | |
| Lisdexamfetamine | (2S)-2,6-Diamino-N-[(2S)-1-phenylpropan-2-yl]hexanamid | |
| Loprazolam | (in doses higher than 2.5 mg) | 6-(2-Chlorphenyl)-2-[(Z)-4-methylpiperazin-1-ylmethylen]-8-nitro-2,4-dihydro-1H-imidazo[1,2-a] [1,4]benzodiazepin-1-on |
| Lorazepam | (in doses higher than 2.5 mg) | (RS)-7-Chlor-5-(2-chlorphenyl)-3-hydroxy-1,3-dihydro-2H-1,4-benzodiazepin-2-on |
| Lormetazepam | (in doses higher than 2 mg) | 7-Chlor-5-(2-chlorphenyl)-3-hydroxy-1-methyl-1,3-dihydro-2H-1,4-benzodiazepin-2-on |
| Medazepam | (in doses higher than 10 mg) | 7-Chlor-1-methyl-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin |
| Methadone | (RS)-6-Dimethylamino-4,4-diphenylheptan-3-on | |
| Methylphenidate | Methyl[(RS;RS)(phenyl)(2-piperidyl)acetat] | |
| Methylphenobarbital | Mephobarbital (in doses higher than 200 mg acid) | (RS)-5-Ethyl-1-methyl-5-phenyl-barbitursäure |
| Midazolam | (in doses higher than 15 mg) | 8-Chlor-6-(2-fluorphenyl)-1-methyl-4H-imidazo[1,5-a] [1,4]benzodiazepin |
| Morphine | (5R,6S)-4,5-Epoxy-17-methyl-morphin-7-en-3,6-diol | |
| Nabilone | (6aRS,10aRS)-1-Hydroxy-6,6-dimethyl-3-(2-methyloctan-2-yl)-6,6a,7,8,10,10a-hexahydro-9H-benzo[c]chromen-9-on | |
| Nimetazepam | 1-Methyl-7-nitro-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-on | |
| Nitrazepam | (in doses higher than 10 mg) | 7-Nitro-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-on |
| Nordazepam | (in doses higher than 15 mg) | 7-Chlor-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-on |
| Normethadone | 6-Dimethylamino-4,4-diphenyl-hexan-3-on | |
| Opium | ||
| Oxazepam | (in doses higher than 50 mg) | 7-Chlor-3-hydroxy-5-phenyl-1,3-dihydro-2H-1,4-benzo-diazepin-2-on |
| Oxazolam | (in doses higher than 20 mg) | (2RS,11bSR)-10-Chlor-2-methyl-11b-phenyl-2,3,7,11b-tetrahydro[1,3]oxazolo[3,2-d] [1,4]benzodiazepin-6(5H)-on |
| Oxycodone | 14-Hydroxydihydrocodeinone | 4,5a-Epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-on |
| Papaver somniferum | ||
| Pemoline | (in doses higher than 20 mg) | 2-Imino-5-phenyl-1,3-oxazolidin-4-on |
| Pentazocine | (2R,6R,11R)-6,11-Dimethyl-3-(3-methylbut-2-en-1-yl)-1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-8-ol | |
| Pentobarbital | (RS)-5-Ethyl-5-(pentan-2-yl)barbitursäure | |
| Pethidine | Meperidine | Ethyl(1-methyl-4-phenyl-piperidin-4-carboxylat) |
| Phenazepam | 7-Brom-5-(2-chlorphenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-on | |
| Phenobarbital | (in doses higher than 300 mg acid) | 5-Ethyl-5-phenylbarbitursäure |
| Phentermine | (in doses higher than 15 mg base) | 2-Benzylpropan-2-ylazan |
| Pinazepam | 7-Chlor-5-phenyl-1-(prop-2-in1-yl)-1,3-dihydro-2H-1,4-benzodiazepin-2-on | |
| Pipradrol | Diphenyl(2-piperidyl)methanol | |
| Piritramide | 1'-(3-Cyan-3,3-diphenylpropyl)[1,4'-bipiperidin]-4'-carboxamid | |
| Prazepam | (in doses higher than 20 mg) | 7-Chlor-1-cyclopropylmethyl-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-on |
| Remifentanil | Methyl{3-[4-methoxycarbonyl-4-(N-phenylpropanamido)piperidino]propanoat} | |
| Remimazolam | Methyl{3-[(4S)-8-brom-1-methyl-6-(pyridin-2-yl)-4H-imidazo[1,2-a][1,4]benzodiazepin-4-yl]propanoat} | |
| Secobarbital | 5-Allyl-5-(pentan-2-yl)barbitursäure | |
| Sufentanil | N-{4-Methoxymethyl-1-[2-(2-thienyl)ethyl]-4-piperidyl}-N-phenylpropanamid | |
| Tapentadol | 3-[(2R,3R)-1-Dimethylamino-2-methylpentan-3-yl]phenol | |
| Temazepam | (in doses higher than 20 mg) | (RS)-7-Chlor-3-hydroxy-1-methyl-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-on |
| Tetrazepam | (in doses higher than 100 mg) | 7-Chlor-5-(cyclohex-1-enyl)-1-methyl-1,3-dihydro-2H-1,4-benzodiazepin-2-on |
| Tilidine | trans-Tilidine (in doses higher than 300 mg base or with less than 7.5% Naloxone hydrochloride) | Ethyl[(1RS,2SR)-2-dimethyl-amino-1-phenylcyclohex-3-encarboxylat] |
| Triazolam | (in doses higher than 0.25 mg) | 8-Chlor-6-(2-chlorphenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-a] [1,4]benzodiazepin |
| Zolpidem | (in doses higher than 8.5 mg base = 10.625 mg tartrate) | N,N-Dimethyl-2-[6-methyl-2-(p-toly)imidazo[1,2-a]pyridin-3-yl]acetamid |
As well as salts of the substances listed in Anlage III.
See also
[edit]References
[edit]- ^ "Gesetz über den Verkehr mit Betäubungsmitteln (Betäubungsmittelgesetz - BtMG) Anlage I (zu § 1 Abs. 1) (nicht verkehrsfähige Betäubungsmittel)" (in German). Bundesministerium für Justiz und Verbraucherschutz.
- ^ a b "§ 3 BtMG - Einzelnorm". www.gesetze-im-internet.de (in German). Bundesamt fur Justiz. 1981. Retrieved 9 April 2018.
(1) Einer Erlaubnis des Bundesinstitutes für Arzneimittel und Medizinprodukte bedarf, wer
[(1) A permit from the Federal Institute for Drugs and Medical Devices is required for anyone who
1. Betäubungsmittel anbauen, herstellen, mit ihnen Handel treiben, sie, ohne mit ihnen Handel zu treiben, einführen, ausführen, abgeben, veräußern, sonst in den Verkehr bringen, erwerben oder
2. ausgenommene Zubereitungen (§ 2 Abs. 1 Nr. 3) herstellen will.
(2) Eine Erlaubnis für die in Anlage I bezeichneten Betäubungsmittel kann das Bundesinstitut für Arzneimittel und Medizinprodukte nur ausnahmsweise zu wissenschaftlichen oder anderen im öffentlichen Interesse liegenden Zwecken erteilen.
1. Intends to cultivate, manufacture, trade in, import, export, deliver, sell, otherwise place on the market, acquire, or
2. Manufacture exempted preparations (Section 2 (1) No. 3) in exceptional cases.
(2) The Federal Institute for Drugs and Medical Devices may only grant a permit for the narcotics listed in Annex I for scientific or other purposes in the public interest.] - ^ "Gesetz über den Verkehr mit Betäubungsmitteln (Betäubungsmittelgesetz - BtMG) Anlage II (zu § 1 Abs. 1) (verkehrsfähige, aber nicht verschreibungsfähige Betäubungsmittel)" (in German). Bundesministerium für Justiz und Verbraucherschutz.
- ^ "Gesetz über den Verkehr mit Betäubungsmitteln (Betäubungsmittelgesetz - BtMG) Anlage III (zu § 1 Abs. 1) (verkehrsfähige und verschreibungsfähige Betäubungsmittel)" (in German). Bundesministerium für Justiz und Verbraucherschutz.
- ^ "§ 13 BtMG - Einzelnorm". www.gesetze-im-internet.de (in German). Retrieved 9 April 2018.
Die in Anlage III bezeichneten Betäubungsmittel dürfen nur von Ärzten, Zahnärzten und Tierärzten und nur dann verschrieben oder im Rahmen einer ärztlichen, zahnärztlichen oder tierärztlichen Behandlung einschließlich der ärztlichen Behandlung einer Betäubungsmittelabhängigkeit verabreicht oder einem anderen zum unmittelbaren Verbrauch oder nach Absatz 1a Satz 1 überlassen werden, wenn ihre Anwendung am oder im menschlichen oder tierischen Körper begründet ist. Die Anwendung ist insbesondere dann nicht begründet, wenn der beabsichtigte Zweck auf andere Weise erreicht werden kann.
[The narcotics listed in Annex III may only be prescribed by doctors, dentists and veterinarians or administered as part of medical, dental or veterinary treatment, including medical treatment for narcotic addiction, or made available to another person for immediate consumption or in accordance with paragraph 1a, sentence 1, if their use on or in the human or animal body is justified. In particular, use is not justified if the intended purpose can be achieved by other means.] - ^ "Bericht des Ausschusses für Bildung, Forschung und Technikfolgenabschätzung (18. Ausschuss) gemäß § 56a der Geschäftsordnung Technikfolgenabschätzung (TA) Pharmakologische Interventionen zur Leistungssteigerung als gesellschaftliche Herausforderung" [Report of the Committee on Education, Research and Technology Assessment (18th Committee) pursuant to Section 56a of the Rules of Procedure: Technology Assessment (TA) Pharmacological Interventions to Enhance Performance as a Societal Challenge] (PDF). dip21.bundestag.de (in German). Deutscher Bundestag. 24 November 2011. p. 66. Drucksache 17/7915. Retrieved 25 September 2025.
Fachinformationen sind nur für Fachkreise zugänglich, die Bewerbung ist auf diese Personengruppe beschränkt.
[Technical information is available only to medical professionals, and advertising is restricted to this group.]